6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA 36C24426Q0216
Summary
AI-generated · Feb 13, 2026Lenalidomide capsules in two strengths (5 mg and 25 mg), oral, are being procured under the FAR Part 8 Federal Supply Schedule using a Lowest Price Technically Acceptable evaluation, with 273 units of each strength at the Coatesville site.
The base period lasts one year starting in February 2026. The award amount is $249,412.80, issued to EXELAN PHARMACEUTICALS INC.
Specialty Pharmaceutical Lenalidomide Coatesville 0001 273.00 EA __________________ __________________ Lenalidomide 5MG CAP, ORAL Contract Period: Base POP Begin: 02-06-2026 POP End: 02-05-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals 0002 273.00 EA __________________ __________________ Lenalidomide 25MG CAP, ORAL Contract Period: Base POP Begin: 02-06-2026 POP End: 02-05-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals
From Award Notice posted on Feb 12, 2026Notice history
1Details
Award Information
Award Notices
Posted: Feb 12, 2026
Specialty Pharmaceutical Lenalidomide Coatesville 0001 273.00 EA __________________ __________________ Lenalidomide 5MG CAP, ORAL Contract Period: Base POP Begin: 02-06-2026 POP End: 02-05-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs...
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | FYZXNHSQTMG8 | 6GFC4 | BOCA RATON |
Contacts
Contract Specialist
Phone